Skip to content

Clinical trials

Phase 3 Primary Myelofibrosis trials in Spain

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Primary Myelofibrosis Phase: Phase 3 Country / region: Spain Clear all

22 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20091
20101
20111
20131
20141
20161
20171
20191
20203
20216
20241
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed10
Active, not recruiting6
Recruiting3
Terminated3

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals6
Celgene3
Sierra Oncology LLC - a GSK company3
AbbVie2
Incyte Corporation2
European Organisation for Research and Treatment of Cancer - EORTC1
Geron Corporation1
Kartos Therapeutics, Inc.1
Karyopharm Therapeutics Inc1
Swedish Orphan Biovitrum1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Primary Myelofibrosis22
Myeloproliferative Disorders7
Anemia5
Neoplasms3
Bone Marrow Diseases2
Hematologic Diseases2
Anemia, Diamond-Blackfan1
Anemia, Sickle Cell1
Blast Crisis1
Blood Platelet Disorders1

Trials

Showing 1 to 22 of 22. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.